AMRN — AMARIN CORP PLC\UK
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 897448 ·
Ireland
Last close
$15.77
Market Cap
$330.68M
52W High
$16.13
52W Low
$12.96
ADV30
70,088
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 45,132,000 | 17,769,000 | -8,011,000 | -10,512,000 | 645,764,000 | 131,063,000 | 196,351,000 |
| Dec 2025 | 49,219,000 | 23,169,000 | -2,261,000 | -1,224,000 | 670,775,000 | 134,660,000 | 211,494,000 |
| Sep 2025 | 49,670,000 | 22,208,000 | -1,697,000 | -7,738,000 | 659,814,000 | 122,802,000 | 200,920,000 |
| Jun 2025 | 72,741,000 | 50,362,000 | 6,774,000 | -14,139,000 | 670,126,000 | 147,877,000 | 205,202,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$25,575,000
Investing CF
$-11,533,000
Financing CF
$-2,602,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.60
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,717,856,000
Inventory
$183,585,000
Receivables
$108,051,000
ST Investments
$176,759,000
EBIT TTM
$-27,295,000
Pretax Income TTM
$-31,140,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$216,760,992
EBITDA
$-2,261,000
Free Cash Flow
$2,224,500
Enterprise Value
$17,980,384
Total Cash
$307,822,016
Total Debt
$7,701,000
Shares Out
20,969,109
Trailing EPS
$-1.60
Book Value
$21.42
ROE
-7.3%
ROA
-0.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 213,646,000 | -13,941,000 | -38,798,000 | 670,775,000 | 211,494,000 | — | 6,728,000 |
| Dec 2024 | 228,614,000 | -91,797,000 | -82,183,000 | 685,349,000 | 199,173,000 | — | -31,020,000 |
| Dec 2023 | 306,911,000 | -56,616,000 | -59,112,000 | 831,684,000 | 279,587,000 | — | 6,880,000 |
| Dec 2022 | 369,193,000 | -92,343,000 | -105,803,000 | 886,179,000 | 290,846,000 | — | -180,092,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.98
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $15.77 · call volume: 68 · put volume: 17
Expected Move to 2026-09-18:
±$6.29
(39.92%) —
implied range
$9.48 –
$22.07
· ATM straddle on $16.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NVCT | Nuvectis Pharma, Inc. | $333.96M | $12.59 | — |
| UPB | Upstream Bio, Inc. | $334.68M | $6.15 | — |
| IRD | Opus Genetics, Inc. | $335.22M | $4.06 | — |
| ABEO | ABEONA THERAPEUTICS INC. | $322.02M | $5.65 | — |
| CATX | Perspective Therapeutics, Inc. | $339.86M | $2.98 | — |
News headlines (Yahoo Finance, 1h cache)
Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?
2026-06-12 13:40 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-06-09 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
2026-06-08 15:10 · Yahoo
Generic drugmakers gain key victory in ‘skinny label’ patent case
2026-06-05 11:51 · Yahoo
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma
2026-06-04 21:39 · Yahoo
Sector Update: Healthcare Stocks Climb Late Afternoon
2026-06-04 19:50 · Yahoo
Update: Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
2026-06-04 17:25 · Yahoo
Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
2026-06-04 15:12 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
2026-05-28 15:14 · Yahoo
Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN)
2026-05-27 15:24 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.